文献速递腹部技术与安全CT

基于人工智能的CT体成分分析识别肌脂肪变性为无症状成人关键死亡预测因子

AI-based CT Body Composition Identifies Myosteatosis as Key Mortality Predictor in Asymptomatic Adults.
PubMed 文献 · Radiology · 2023-05-16

本回顾性单中心研究纳入2004年4月至2016年12月期间接受常规结直肠癌筛查的8982例连续成人门诊患者,利用U-Net算法从低剂量非增强仰卧位腹部CT提取体成分指标。中位随访8.8年,结果显示肌脂肪变性与死亡风险升高相关(多变量校正后HR 1.89,95%CI 1.52-2.35,P<.001),提示其可作为无症状成人死亡风险的关键预测因子。

要点

  • 肌脂肪变性(肌肉脂肪浸润)是无症状成人死亡风险的关键独立预测因子。
  • 常规低剂量非增强腹部CT即可用AI自动提取体成分,无需额外扫描。
  • 死亡者中86%存在体成分异常,肌脂肪变性者10年绝对风险为15.5%。

核心结论

  • 基于常规腹部CT的AI体成分分析识别出肌脂肪变性是无症状成人死亡风险的关键预测因子。

研究设计与样本

  • 回顾性单中心研究,纳入2004年4月至2016年12月连续成人门诊结直肠癌筛查患者8982例,采用U-Net算法从低剂量非增强仰卧位多排腹部CT提取体成分指标,中位随访8.8年,参考标准为死亡及主要不良心血管事件。

关键影像表现/征象

  • CT可定量提取总肌肉面积、肌肉密度、皮下及内脏脂肪面积和容积肝密度等体成分指标。
  • 体成分异常定义为存在肝脂肪变、肥胖、肌肉脂肪浸润(肌脂肪变性)和/或低肌肉量(肌少症)。
  • 随访期间死亡患者中86%(434/507)存在体成分异常。

诊断标准与关键数值

  • 肌脂肪变性与死亡风险升高相关,HR 4.33(95%CI 3.63-5.16)。
  • 肥胖与死亡风险升高相关,HR 1.27(95%CI 1.06-1.53)。
  • 肝脂肪变与死亡风险升高相关,HR 1.86(95%CI 1.56-2.21)。
  • 肌少症与死亡风险升高相关,HR 1.75(95%CI 1.43-2.14)。
  • 在8303例(排除679例数据不完整者)中多变量校正后,肌脂肪变性仍与死亡风险升高相关,HR 1.89(95%CI 1.52-2.35;P<.001)。

临床应用与阅片要点

  • 在阅片和报告中可关注常规腹部CT上的肌脂肪变性(肌肉密度减低)等体成分指标,其与死亡风险升高相关。
  • U-Net算法可从低剂量非增强仰卧位腹部CT自动提取体成分指标,便于在筛查人群中应用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Body composition data have been limited to adults with disease or older age. The prognostic impact in otherwise asymptomatic adults is unclear. Purpose To use artificial intelligence-based body composition metrics from routine abdominal CT scans in asymptomatic adults to clarify the association between obesity, liver steatosis, myopenia, and myosteatosis and the risk of mortality. Materials and Methods In this retrospective single-center study, consecutive adult outpatients undergoing routine colorectal cancer screening from April 2004 to December 2016 were included. Using a U-Net algorithm, the following body composition metrics were extracted from low-dose, noncontrast, supine multidetector abdominal CT scans: total muscle area, muscle density, subcutaneous and visceral fat area, and volumetric liver density. Abnormal body composition was defined by the presence of liver steatosis, obesity, muscle fatty infiltration (myosteatosis), and/or low muscle mass (myopenia). The incidence of death and major adverse cardiovascular events were recorded during a median follow-up of 8.8 years. Multivariable analyses were performed accounting for age, sex, smoking status, myosteatosis, liver steatosis, myopenia, type 2 diabetes, obesity, visceral fat, and history of cardiovascular events. Results Overall, 8982 consecutive outpatients (mean age, 57 years ± 8 [SD]; 5008 female, 3974 male) were included. Abnormal body composition was found in 86% (434 of 507) of patients who died during follow-up. Myosteatosis was found in 278 of 507 patients (55%) who died (15.5% absolute risk at 10 years). Myosteatosis, obesity, liver steatosis, and myopenia were associated with increased mortality risk (hazard ratio [HR]: 4.33 [95% CI: 3.63, 5.16], 1.27 [95% CI: 1.06, 1.53], 1.86 [95% CI: 1.56, 2.21], and 1.75 [95% CI: 1.43, 2.14], respectively). In 8303 patients (excluding 679 patients without complete data), after multivariable adjustment, myosteatosis remained associated with increased mortality risk (HR, 1.89 [95% CI: 1.52, 2.35]; P < .001). Conclusion Artificial intelligence-based profiling of body composition from routine abdominal CT scans identified myosteatosis as a key predictor of mortality risk in asymptomatic adults. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Tong and Magudia in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Nachit, Horsmans, Summers, et al. AI-based CT Body Composition Identifies Myosteatosis as Key Mortality Predictor in Asymptomatic Adults. Radiology. 2023. PMID: 37191484. doi:10.1148/radiol.222008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。